Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (151-160 of 353) with videos related to

Pageof 36
Sort By:
Archives of Internal Medicine|October 24, 2007
Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO VHarmony R Reynolds, Michael E Farkouh, A Michael Lincoff, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 7, 2006
Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF studyNicholas G Smedira, Cornelius M Dyke, Andreas Koster, et al.
The American Journal of Medicine|July 11, 2002
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularizationEric J Topol, A Michael Lincoff, Dean J Kereiakes, et al.
Journal of Interventional Cardiology|August 26, 2009
Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trialsJacob A Doll, Eugenia Nikolsky, Gregg W Stone, et al.
European Journal of Preventive Cardiology|February 16, 2026
Effect of bempedoic acid on cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver diseaseVivian D de Jong, Steven E Nissen, William J Sasiela, et al.
JAMA|August 21, 2003
Prevalence of conventional risk factors in patients with coronary heart diseaseUmesh N Khot, Monica B Khot, Christopher T Bajzer, et al.
European Journal of Preventive Cardiology|February 11, 2017
The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trialSigrid Cj van Steen, Ilse C Schrieks, Joost Bl Hoekstra, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2005
Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury modelKai Wang, Zhongmin Zhou, Ming Zhang, et al.
Journal of the Endocrine Society|February 6, 2025
Testosterone Replacement Therapy and Risk of COVID-19 and Effect of COVID-19 on Testosterone's Treatment EffectKarol M Pencina, A Michael Lincoff, Eric A Klein, et al.
Journal of Clinical Lipidology|February 12, 2025
Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trialUlrich Laufs, A Michael Lincoff, Stephen J Nicholls, et al.
Pageof 36

Showing results (151-160 of 353) with videos related to

Sort By:
Pageof 36
Archives of Internal Medicine|October 24, 2007
Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO VHarmony R Reynolds, Michael E Farkouh, A Michael Lincoff, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 7, 2006
Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF studyNicholas G Smedira, Cornelius M Dyke, Andreas Koster, et al.
The American Journal of Medicine|July 11, 2002
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularizationEric J Topol, A Michael Lincoff, Dean J Kereiakes, et al.
Journal of Interventional Cardiology|August 26, 2009
Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trialsJacob A Doll, Eugenia Nikolsky, Gregg W Stone, et al.
European Journal of Preventive Cardiology|February 16, 2026
Effect of bempedoic acid on cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver diseaseVivian D de Jong, Steven E Nissen, William J Sasiela, et al.
JAMA|August 21, 2003
Prevalence of conventional risk factors in patients with coronary heart diseaseUmesh N Khot, Monica B Khot, Christopher T Bajzer, et al.
European Journal of Preventive Cardiology|February 11, 2017
The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trialSigrid Cj van Steen, Ilse C Schrieks, Joost Bl Hoekstra, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2005
Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury modelKai Wang, Zhongmin Zhou, Ming Zhang, et al.
Journal of the Endocrine Society|February 6, 2025
Testosterone Replacement Therapy and Risk of COVID-19 and Effect of COVID-19 on Testosterone's Treatment EffectKarol M Pencina, A Michael Lincoff, Eric A Klein, et al.
Journal of Clinical Lipidology|February 12, 2025
Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trialUlrich Laufs, A Michael Lincoff, Stephen J Nicholls, et al.
Pageof 36